The global funding landscape is buzzing again. In one of the strongest weeks of 2025, investors poured billions into startups spanning wearables, biotech, SaaS, and quick commerce. From Oura’s health insights to Zepto’s delivery dominance, this week’s deals redefine what “smart growth” with renewed optimism which signals that venture capital is back in growth mode — and AI continues to shape the investment narrative.
Here are the five top startup funding deals announced during the week ending October 21st, 2025, as curated from the Intellizence Startup Funding Dataset.
💸 Funding Highlights
| Company | Sector | Funding Amount | Valuation | Round Lead Investor |
|---|---|---|---|---|
| Oura Ring | Technolgy | $900M | $11B | Venture - Series Unknown |
| Kailera Therapeutics | Biotechnolgy | $600M | —- | Series B |
| Zepto | E-Commerce | $450M | $7B | Venture - Series Unknown |
| Deel | HR & Payroll Technology | $400M | $17.3B | Series E |
| Vantaca | Technology | $300M | $1.25b | Venture - Series Unknown |
Smart ring maker Oura raises $900M from Fidelity
Funding Amount: $900 million
Funding Round: Series E
Industry: Technology
Country: United States
Oura raised $900 million in a late-stage round (Series E) at a valuation of about $11 billion.
Led by major investors including Fidelity Management & Research Company, with participation from firms such as Iconiq Capital, Whale Rock Capital and Atreides Capital.
The funds will be used to expand global distribution of its smart ring product and scale production: “scale production, invest in development, and expand its international presence.”
Oura intends to evolve from sleep tracking to an overall “proactive health” platform.
Kailera Therapeutics Secures $600 Million
Funding Amount: $600 Million
Funding Round: Series B
Industry: Biotechnology
Country: United States
Kailera raised $600 million in a Series B financing round. The company is focused on obesity and metabolic disorders (dual GLP-1/GIP receptor agonists, among other therapies). The funding will help launch a global Phase III clinical program for its lead candidate (KAI-9531) targeting obesity. It will also enable scalability of clinical development, global regulatory engagement, and possibly manufacturing and commercialization readiness ahead of launch.
Zepto Raised $450 Million at a $7 Billion Valuation
Funding Amount: $450 Million
Funding Round: Venture-Series-Unknown
Industry: E-Commerce
Country: India
Zepto raised $450 million at a $7 billion valuation. The round included contributions from new and existing investors, such as California Public Employees’ Retirement System (“CalPERS”), General Catalyst, Goodwater Capital and Lightspeed Venture Partners. The funds will be used to expand its network of so-called “dark stores” or micro-fulfilment centres, scale its product range and geographical footprint (India, new cities).
Deel’s Raised $300 Million Valuing the Company at $17.3 Billion
Funding Amount: $300 Million
Funding Round: Series E
Industry: Technology
Country: United States
Deel raised $300 million in its Series E round at a valuation of $17.3 billion. The round was led by new investor Ribbit Capital alongside existing backers such as Andreessen Horowitz and Coatue Management. Funding will be used to expand infrastructure and global payroll capabilities: Deel aims to support native payroll in more than 100 countries by 2029. It will also be used to advance AI-powered payroll, HR and banking products.
Vantaca Raises $300 Million at $1.25 Billion Valuation
Funding Amount: $300 Million
Funding Round: Venture – Series Unknown
Industry: Technology
Country: United States
Vantaca has secured a $300 million+ growth investment (minority growth round) at a valuation of $1.25 billion.The round was led by Cove Hill Partners and involved existing investor JMI Equity. The funds will help deepen AI-driven automation capabilities for community association management companies (CAMs), accelerate go-to-market expansion, and integrate more services for boards, residents, vendors and management firms to provide a full-stack platform.
Billion-Dollar Bets
These five deals collectively represent over $3 billion in capital deployment across cutting-edge sectors, demonstrating that investors remain bullish on transformative technologies and infrastructure despite broader economic uncertainties. From health and biotech to HR tech and quick commerce, the week’s deals show wide investor appetite.
FAQ
What is the Intellizence Fundraising Dataset?
The Intellizence Fundraising Dataset tracks verified startup and corporate fundraising events worldwide. It provides structured intelligence on venture capital, private equity, and corporate investment rounds, helping users identify emerging companies, technologies, and investors.
How is fundraising data collected and verified?
Intellizence combines AI-powered news extraction with human curation to ensure data accuracy. Information is gathered from:
- Company and investor press releases
- Regulatory filings (e.g., SEC Form D)
- Venture capital databases
- Reliable business news sources and wire services
Who uses the Fundraising Dataset?
The dataset is widely used by:
- Venture capital and private equity firms for deal sourcing
- Investment banks and analysts for market intelligence
- Corporate innovation and M&A teams for identifying acquisition targets
- Consulting and research firms for sector trend analysis
- Sales and marketing teams for lead generation in high-growth startups
Identify Emerging Opportunities & Risks